Mary Stapleton has over 15 years experience in Pharmacovigilance and Clinical Trials in Ireland, UK, France, and Hungary. Prior to her career as a consultant, Mary was Pharmacovigilance Manager of Cancer Trials Ireland for seven years and held a number of pharmacovigilance positions at Quintiles (now IQVIA). Mary also had a pharmacovigilance role with the Hungarian national competent authority.
Mary earned her Ph.D. in the Department of Pharmacology and Therapeutics, University College Cork, Ireland and her Pharmacovigilance Diploma from the University of Hertfordshire, UK.
Mary joined Cilatus as subject matter expert on Pharmacovigilance regulations. She contributes to our clients in the area of Pharmacovigilance standard operating procedure (SOP) development and Pharmacovigilance training.